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Abstract: Fatigue is an often-neglected symptom but frequently complained of by older people,
leading to the inability to continue functioning at a normal level of activity. Fatigue is frequently
associated with disease conditions and impacts health status and quality of life. Yet, fatigue cannot
generally be completely explained as a consequence of a single disease or pathogenetic mechanism.
Indeed, fatigue mirrors the exhaustion of the physiological reserves of an older individual. Despite its
clinical relevance, fatigue is typically underestimated by healthcare professionals, mainly because
reduced stamina is considered to be an unavoidable corollary of aging. The incomplete knowledge of
pathophysiological mechanisms of fatigue and the lack of a gold standard tool for its assessment
contribute to the poor appreciation of fatigue in clinical practice. Inadequate nutrition is invoked
as one of the mechanisms underlying fatigue. Modifications in food intake and body composition
changes seem to influence the perception of fatigue, probably through the mechanisms of inflammation
and/or mitochondrial dysfunction. Here, we present an overview on the mechanisms that may
mediate fatigue levels in old age, with a special focus on nutrition.
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1. Overview
Aging is accompanied by substantial changes in body composition, the most notable of which are
a reduction of lean body mass and increased adipositiy. These modifications are important contributors
to the onset of frailty in older persons. Frailty is a complex condition characterized by reduced
homoeostatic reserves, resulting in increased vulnerability to stressors. It is associated with several
adverse outcomes, including falls, hospitalization, functional decline, and mortality [1,2]. Several tools
have been developed and validated over the years for identifying frail individuals. Interestingly,
most of the available tools, more or less explicitly, include the concept of fatigue [1]. In other words,
fatigue seems to be often considered a typical manifestation of the aging individual, a symptom making
evident the effects of advancing age on the organism.
Despite its high prevalence and the burden it poses over the person, fatigue remains an often
neglected symptom. It is usually defined as a state associated with the weakening and/or depletion of
the individual’s physical and/or mental resources. Its heterogeneous phenotype is described as ranging
from a general state of lethargy to a very specific work-induced burning muscular sensation. It leads
to the inability to continue functioning at the normal level of activity [3]. Physical fatigue, although
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widespread in everyday life, usually becomes particularly noticeable during heavy exercise. On the
other hand, mental fatigue most often manifests as somnolence [3]. Despite its inclusion in the DSM-5,
fatigue is often defined and operationalized in heterogeneous ways. Depending on how the symptom
is referred, several terms are interchangeably used to define fatigue, such as tiredness, exhaustion,
fatigability, low vitality, anergia, weakness, and lassitude [4,5]. Tiredness, which is one of the most
widely used terms to describe the symptom of fatigue, has been depicted as a transitory decrease of
strength and energy [6], and can be relieved by sleep and rest [4]. On the other hand, “vital exhaustion”
is a conceptualization of fatigue often used in the cardiology setting, and encompasses lack of energy,
increased irritability, and the feeling of demoralization [5].
Fatigue is strongly associated with poor physical performance [7], and represents a strong predictor
of multiple negative outcomes in older persons (including hospitalizations, increased use of healthcare
services, incident disability, mortality) [8–10]. It is frequently observed in many diseases (e.g., cancer,
neurodegenerative disorders, rheumatologic disease, heart failure) and can directly and indirectly
affect the individual’s health status and quality of life. Indeed, fatigue is a prolonged symptom in many
neurologic and muscular disorders, such as multiple sclerosis, myasthenia gravis and fibromyalgia
affecting both the psychological and the physical domain [11,12]. On the other hand, fatigue may be
an isolated and persistent symptom with unknown etiology, the so-called “chronic fatigue syndrome”
(CFS) [5,11]. Nevertheless, for many older persons, fatigue can hardly be univocally ascribed to or
completely explained by a single disease. It often remains an unexplained symptom with unclear
pathophysiological mechanisms [13]. Yet, fatigue may represent the clinical alert launched by the
organism with a limited homeostatic capacity in front of a disproportionate stressor challenging it [14].
Although the prevalence of fatigue is estimated to be between 6% and 45% in community-dwelling
older persons [15], these figures are likely underestimating the phenomenon. In fact, fatigue is a largely
neglected symptom in both clinical and research settings. Given the lack of a gold standard for the
assessment of fatigue, its evaluation in older persons requires a complex methodological framework
that needs to take into account the underlying effects of the aging process (altering the standard
definitions of normality versus abnormality). Moreover, the subjective symptom of fatigue does not yet
receive adequate attention in clinical settings, at least not as much as other similar/related conditions
(e.g., depression and pain). Like fatigue, pain and depression are subjective feelings characterized by
high prevalence older persons and are associated with negative clinical endpoints [16,17]. Fatigue,
pain and depression often coexist and synergistically act in the vicious circle of the disabling process.
However, if pharmacological (largely symptomatic) remedies exist for pain and depression, no effective
treatments are currently available for alleviating the burdening symptom of fatigue. The most
promising ways to understand the pathophysiological mechanisms underlying fatigue seem to be sleep
parameters, autonomic nervous system abnormalities, and biological complexity [4,14]. In particular,
nutritional status plays an important role as a mediator of fatigue both directly and indirectly by
mediating its underlying mechanisms. Fatigue may, in fact, mimic the exhaustion of the metabolic
reserves of the individual. In this context, the aim of the present article was to provide an overview of
the patterns, with a special focus on nutrition, which may influence fatigue levels in older people.
2. Biological Complexity
Fatigue is a quite complex and multidimensional symptom. The underlying mechanism potentially
modulating fatigue are not completely known but may include quite a lot of biological patterns which
might help understand it. Modifications of cardiac function, chronic inflammatory status, skeletal
muscle modifications, nutritional deficiencies and sleep disorders may influence fatigue [4,5]. General
cardiac functioning [18] and reduced aerobic capacity [9,19,20] are related to fatigue. Pain may
contribute to fatigue by increasing heart rate, blood pressure, respiratory rate, muscle tone, and oxygen
consumption [21]. Furthermore, sleep disorders both in qualitative and quantitative domains (which are
common in the older population) may contribute to the fatigue onset. In fact, it has been reported
that people with a short sleep duration are usually more fatigued than those who sleep for longer
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periods [22]. Noticeably, older persons who report sleeping problems are more fatigued than others [23].
Sleep deprivation has also been associated with metabolic alterations. Among healthy individuals with
experimentally induced sleep-deprivation, cortisol levels and calorie intake increase, while glucose
tolerance and leptin levels decrease [24,25]. Sleepiness and fatigue are difficult to differentiate. The two
conditions may lead to a reduction in physical activity or induce consumption of more calories as
an attempt to boost energy levels [26]. Moreover, modifications in body composition and dietary
changes may contribute both to fatigue and its underlying conditions (i.e., sleep disorders, depression,
skeletal muscle modifications).
3. Assessment
Given the subjective nature of the symptom, the measurement of fatigue is quite complex. Indeed,
despite the several tools have been validated to measure fatigue and may be predictive of adverse
outcomes, none of them is considered as a gold standard [4,5]. For example, unidimensional scales
are focused on specific features of the symptom (i.e., fatigue severity) and on specific populations
(i.e., cancer patients). This is the case of the Brief Fatigue Inventory [27], which is a 9-item scale
developed in the oncology setting, measuring fatigue severity. On the other hand, multidimensional
tools are more detailed and provide information about the nature of the symptom, its intensity and
the impact on activities of daily living (ADL) [5]. To date, the Multidimensional Fatigue Inventory
is a 20-item scale, validated both under normal and pathologic conditions, which includes different
aspects of the symptom such as its nature (i.e., general, physical or mental), reduced activities and
motivation [28]. Several other tools, including the concept of fatigue, may provide information about
fatigue. For example, the Short Form-36 (SF-36) Vitality scale, is a part of the Short-Form-36 Health
Survey developed as a generic indicator of health status [29,30]. The SF-36 Vitality scale consists of four
items based on energy and fatigue and has been validated both in general and pathologic populations.
Another example is the criterion of “exhaustion” included in the frailty phenotype proposed by Fried et
al. in the Cardiovascular Health Study Frailty Screening Scale [31,32]. However, this operationalization
does not completely capture the multidimensionality of the symptom.
4. Modifications of Food Intake
Advancing age is characterized by multiple changes (e.g., physiological, psycho-social and
pathological changes) (Table 1) leading to poor appetite and impacting on the quantity and/or quality
of food consumed [33]. This condition has been defined as “anorexia of aging”, a disorder potentially
leading to malnutrition [34,35].
Table 1. Major changes occurring with aging.
Physiological Pathological Psychosocial
Digestive system Diseases Depression
Hormonal Medications Financial status
↓ taste and smell Neurological disorders Anxiety
↑ energy expenditure Swallowing problems Sleep disorders
Early satiety Poor dentition ↓ Ability to shop or prepare meals
Cytokines Poor mobility Loneliness
Xerostomia
↓ = decreased, ↑ = increased.
Undernutrition may result in weight loss and nutritional deficiencies leading to fatigue by means
of “lack of energy” (a key concept of fatigue) [5,36–38]. When protein and energy intakes fail to meet
individuals need, body stores are catabolized to provide energy, leading to the depletion of body fat and
muscle [39,40] with consequent symptoms such as fatigue or tiredness [36,38]. Poor nutritional status is
also associated with reduced physical performance leading to fatigue [38]. Furthermore, there appears
to be a bi-directional association between undernutrition and fatigue. In fact, while undernourished
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people are more prone to experience fatigue symptoms, fatigued people may be at risk of undernutrition
by means of a lack of energy to prepare a meal [37].
Chronic low-grade inflammation, a hallmark of the aging process, is acknowledged as one of
the major determinants of age-related anorexia. The so-called inflamm-aging is characterized by
increased circulating concentrations of cytokines (e.g., interleukin (IL) 1, IL-6, and tumor necrosis factor
alpha (TNF-α)) [35,41], responsible for a reduction of food intake, altered metabolism (i.e., elevation
of resting energy expenditure), and increased muscle catabolism, eventually resulting in the risk of
malnutrition [42]. Additionally, it is well documented that micronutrient deficiencies may determine
oxidative stress and consequently, feed a vicious circle with inflammation. Chronic low-grade
inflammation has also been implicated in mediating a wide range of chronic conditions characterized
by the presence of fatigue [43].
Excessive food consumption leading to obesity may also be a contributing factor to fatigue
symptoms. It has been reported that excessive dietary intake, in particular, high fat consumption,
may alter sleep parameters (i.e., daytime sleepiness, poor nocturnal sleep quality and sleep apnea),
then resulting in fatigue [44–47]. Moreover, a high-carbohydrate meal (especially in simple sugar)
may alter sleep indexes and result in subjective fatigue symptoms [45,48,49]. In fact, in response to
ingestion of high-fat and high-sugar foods, circulating levels of glucose, insulin, leptin, cholecystokinin
(CCK), peptide YY, and enterostatin are increased, all of which have somnogenic effects [45]. CCK is
a short-term satiety hormone released after a fatty meal which could mediate sleep quality parameters
and that was also reported to be predictive of and positively correlated with fatigue [49]. Long-term
high-fat intake may lead to elevated levels of leptin (an adiposity hormone) and decreased levels
of ghrelin [50], which could regulate arousal and wakefulness via orexin [51]. Excessive leptin
production causes the release of pro-inflammatory cytokines and has also been reported to contribute
to fatigue [52–54]. Indeed, unhealthy diet, inflammation and sleep disorders seem to play a pivotal
role in the complex etiology of fatigue.
5. Modifications in Body Composition
As mentioned above, changes in food intake during aging may impact nutritional status and eventually
contribute to alterations in body composition [55]. In particular, with advancing age, fat mass increases
while muscle mass decreases, with a consequent reduction in resting metabolic rate (RMR) [56].
5.1. Obesity
Despite older people being at a greater risk of undernutrition, in recent years, an increased
prevalence of overweight and obesity in those aged 65+ has also been reported [33]. This issue
is of particular relevance, as obesity status has consistently been related to increased levels of
fatigue [26,57–59] (Table 2). In obese people, fatigue may be mediated by systemic inflammation [60].
In fact, individuals with greater adiposity exhibit elevated levels of C-reactive protein, TNF-α, IL-6,
leptin and resistin [61,62].
Furthermore, obesity status has been related to sleep disorders and vice versa. Sleep disturbances
can result in metabolic (decreased glucose tolerance and insulin sensitivity) and endocrine alterations
such as decreased levels of leptin, increased evening concentrations of cortisol, increased levels of ghrelin
and increased hunger and appetite (all of which promote obesity) [63]. On the other hand, obesity is
also characterized by metabolic (i.e., insulin resistance and decreased glucose tolerance) and endocrine
(elevated cortisol levels but increased leptin and decreased ghrelin levels) alterations [64,65] in the
same domains of sleep disorders. Interestingly, sleep disorders may also be a result of increased levels
of pro-inflammatory cytokines [60]. Therefore, obesity could lead to sleep disorders via the elevation
of pro-inflammatory cytokines with the consequent onset of fatigue. In fact, obesity appears to be
constantly associated to alterations both in qualitative and quantitative sleep domains [58,66]. A number
of studies have identified obesity as an important risk factor for obstructive sleep apnea [45,67,68].
Furthermore, daytime sleepiness as well as fatigue is frequently complained of by obese individuals [69].
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On the basis of the link among sleep alterations, adiposity and metabolic disorders, obesity could thus
represent a ‘chronobiological disease’ [70] mediating fatigue levels. Another interesting issue is that
obesity is frequently associated with symptoms that are related to fatigue such as depression [71] and
pain [72]. Moreover, excessive body weight, in addition to the hindrance of body mass, may jeopardize
the capacity to fulfil many daily tasks, resulting in fatigability.
With aging, there is also a decrease in physical activity levels and an insufficient amount of
physical activity has been associated with fatigue [73]. Recent evidence suggests that physical exercise
may help reduce fatigue; however, older adults (especially those who are frail and/or obese) with
increased levels of fatigue may not have the energy required for exercising and might further decrease
their levels of exercise [21,73]. In fact, deconditioned older people frequently show difficulties even in
the execution of the simple daily activities.
5.2. Undernutrition
Poor nutritional status may be another contributing factor of fatigue. As previously mentioned,
fatigue may mimic the exhaustion of the metabolic reserves of the undernourished individual, a kind
of alert launched by the organism facing a substantial reduction of its reserves. In fact, fatigue is
frequently a symptom of some micronutrient deficiencies [5,74]. What is more, it has been reported
that fatigue may also be a result of the dysphagia–malnutrition relationship [75]. Eating an adequate
amount of food may, in fact, represent a challenge for dysphagic individuals. The meal is a distressing
and fatiguing moment for these persons, who require more time to eat. Additionally, changes in
masticatory function (i.e., tooth loss), leading to the selection of soft and easy-to-chew foods due to
muscular exhaustion [76], can further negatively affect the nutritional status. In fact, chewing problems
and loss of teeth have been associated with both malnutrition [77,78] and fatigue in older people [79].
Dysphagia and masticatory problems could therefore represent disabling conditions fatiguing the
aged organism.
Fatigue might also be looked as a disorder of energy balance since it is frequently reported as
a sensation of low energy. Most of the energy consumed during the day (about 60–70%) can be
ascribed to the RMR [14]. As mentioned above, aging is accompanied by metabolic derangements,
and RMR declines in older people, mainly because of changes in body composition [56]. In addition
to these changes, many co-morbidities may further disrupt the biological homeostasis and trigger
mechanisms requiring extra energy [80]. For instance, thyroid disorders (which are frequent in
older adults) involve derangements in RMR and are often characterized by fatigue [14,81]. In fact,
the hypothalamic-pituitary-thyroid axis regulates physiological energy demands (thyroid hormones
status correlates with body weight and energy expenditure) [82]. Hyperthyroidism is characterized
by a hypermetabolic state associated with increased RMR, weight loss, reduced cholesterol levels,
and increased lipolysis and gluconeogenesis [83,84]. On the other hand, hypothyroidism is characterized
by hypometabolism with reduced RMR, weight gain, increased cholesterol levels, and reduced lipolysis
and gluconeogenesis [85]. These observations could therefore provide a good rationale for a possible
correlation between body changes, metabolic alterations and fatigue symptoms.
5.3. Sarcopenia
Sarcopenia is a progressive loss of muscle mass and strength, leading to reduced functional
capacity, which is very common in older populations [86]. During aging, there is a net shift toward
type I muscle fibers which are slower to contract in comparison with other fibers, but more resistant to
fatigue due to a more efficient capacity for ATP production through aerobic metabolism. In parallel,
there is both an atrophy and a reduction of motor units in type II fibers which are mainly involved
in the muscle loss process. Type II fibers have greater capacity for force production and are faster to
contract than type I, but are less energetically efficient and therefore, more subject to fatigue [87–89].
Following this rationale, several studies have shown that old individuals develop less muscle fatigue
than their younger counterparts during isometric contractions while complaining of greater fatigue
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during dynamic contractions [90]. However, it is noteworthy that older individuals are more involved
in dynamic tasks for ADL, requiring a greater percentage of their reduced maximal strength and then
resulting in greater fatigability. Moreover, the majority of the published studies included only healthy
individuals and not other different subpopulations (e.g., frail or sarcopenic).
It is important to bear in mind that sarcopenia is not merely an age-related change of the muscle
but a pathological condition defined under specific cut-off measures of muscle mass, strength and
function [86]. Indeed, sarcopenia is a multi-factorial process and can include disuse, changes in endocrine
function, chronic diseases, inflammation, insulin resistance, mitochondrial abnormalities and nutritional
deficiencies [86,91]. Furthermore, muscle fatigue may be defined as the inability of the muscle to produce
or maintain force [92]. In fact, the force developed by a skeletal muscle that is sufficient to produce fatigue
is a function of the maximum force the muscle can develop. Then, any condition that decreases the
maximum muscle force will predispose to fatigue and reduced muscle function [93].
It is well known that sarcopenia is characterized by a reduction in not only muscle mass but also
muscle strength, leading to decreased functionality. This affects virtually all muscular groups, including
respiratory muscles (e.g., diaphragm) [94,95]. In these context, for intermittently contracting muscle like
the diaphragm, the critical force to result in fatigue is about 40% of the maximum [96]. A reduction
in muscle strength, resulting in a decreased force of contraction of respiratory muscles, can therefore
lead to so-called “respiratory fatigue” [93]. Moreover, sarcopenia of respiratory muscles (in particular of
the diaphragm), may results in decreased force for expulsive airway clearance tasks (i.e., coughing and
sneezing) contributing to increased risk for pneumonia and other respiratory infections [95]. Recent findings
have also suggested a relationship between sarcopenia and chronic obstructive pulmonary disease. In these
patients, fatigue, together with dyspnea, are the most complained of and distressing symptoms [97].
Respiratory muscle fatigue also may be due to a reduction in energy stores of the muscle [93]. Thus, both the
different mechanisms involved in the sarcopenic process and sarcopenia itself, which contribute to
an increased susceptibility to stressors, could lead to a decreased muscle ability to resist fatigue. Regarding
muscle functionality, the reduction in walking performance and in endurance associated with a perception
of exhaustion are all characteristic of sarcopenia [98]. Two of the early symptoms/signs of sarcopenia are,
in fact, feeling weak and difficulty rising from a chair, leading to reduced ADL performance [99]. Recently,
Patino-Hernandez et al. [100] reported an association between two of the sarcopenia-defining variables
(abnormal gait speed and handgrip strength) with fatigue.
Table 2. Overview of discussed studies that explored relationships between fatigue and changes in
body composition, inflammation and mitochondrial dysfunction.
References Study Design and Sample Aim Fatigue Assessment Relevant Results
Obesity/inflammation
Valentine et al., 2009 [61]
Cross-sectional study;
127 community- dwelling
older adults.
Assess the contributions of
adiposity, systemic
inflammation, physical
activity/fitness, sleep quality
and depression on fatigue.
Two items taken from the
Cohen-Hoberman Inventory
of Physical
Symptoms questionnaire.
Women reported more
fatigue than men which was
independently associated
with inflammation,
depression, physical activity
and adiposity, whereas in
men the only independent
predictor was depression.
Valentine et al. 2011 [73] Cross-sectional study; 182older people.
Evaluate the influence of
weight status, physical
activity and inflammation
on fatigue.
Multidimensional
Fatigue Inventory.
Adiposity independently
explained a significant
amount of the variance in
general and physical fatigue.
Resnick et al., 2006 [26]
Cross-sectional study; 3130
participants aged 20 to 59
years in the NHANES.
Examine the relationships
between fatigue and BMI,
waist circumference, leisure
time physical activity,
and macronutrient intake.
Responses to the question,
“Right now would you say
you are feeling energetic,
fresh, average,
tired or exhausted?”
Self-reported fatigue was
associated with higher BMI,
higher waist circumference,
and a reduced likelihood of
getting recommended levels
of physical activity.
Theorell-Haglöw et al.
2006 [59]
Cross-sectional study; 5508
women aged 20 to
60 years.
Analyze the relation
between different risk factors
and excessive daytime
sleepiness and fatigue.
Participants were asked to
state how severe their
problems were regarding
feeling physically tired.
Being overweight was
independently related to
fatigue and excessive
daytime sleepiness.
Lim et al., 2008 [58]
Cross-sectional study; 129
subjects aged 25 to
50 years.
Examine the link between
obesity and
depressive symptoms.
Short form of Profile of
Mood States (POMS–SF)
Fatigue/Inertia subscale.
Scores on POMS–SF Fatigue
were positively associated
with BMI and percent fat.
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Table 2. Cont.
References Study Design and Sample Aim Fatigue Assessment Relevant Results
Obesity/inflammation
Undernutrition/nutritional deficiencies
Singh et al., 2014 [38] Cross-sectional study;47 nursing home residents.
Examine the correlation
between nutritional status
and comprehensive physical
performance measures.
Functional Ability
Questionnaire.
A significant negative
correlation was found
between self-reported
mobility tiredness and BMI.
Westergren et al., 2008 [37]
Cross-sectional pilot study;
89 older people discharged
after stroke.
Explore associations
between mealtime
preparation, eating, fatigue,
mood and nutritional status.
Two questions taken from
the 12-item Short Form
Health Survey.
Having a less favourable
nutritional status was
significantly predicted by
a lack of energy and
high age.
Pennisi et al., 2019 [101] Cross-sectional study;480 older adults.
Evaluate and compare
vitamin D status between
older individuals.
Fatigue severity scale (FSS).
Compared with controls,
subjects with fatigue showed
a significant decrease in
vitamin D levels.
Sarcopenia/mitochondrial dysfunction
Christie et al., 2011 [90]
Systematic Review and
Meta-Analysis of
37 studies.
Compare the differences in
muscle fatigue between
young and older adults.
-
Older people develop less
muscle fatigue than young
adults, particularly during
isometric contractions.
However, the results also
suggest that older adults
develop greater fatigue
during dynamic contractions,
especially when the decline in
power is assessed.
Patino-Hernandez
et al., 2017 [100]
Cross-sectional study;
1509 older adults.
Examine the association
among sarcopenia and its
elements with depression
and fatigue.
Fatigue was assessed by
inquiring the participants:
“In the last week: how many
times have you felt that
everything you do is
an effort?”
Sarcopenia did not display
statistically significant
association with either
depression or fatigue.
However, both abnormal
gait speed and grip strenght
(two of the
sarcopenia-defining
variables) were associated
with fatigue.
Wawrzyniak et al.,
2016 [102]
48 subjects aged 65+
categorized into idiopathic
chronic fatigue (ICF) and
non-fatigued (NF) groups
Determine whether skeletal
muscle mitochondrial
dysregulation and oxidative
stress is linked to ICF in
older adults.
Functional assessment of
chronic illness therapy
(FACIT) fatigue scale.
Vastus lateralis muscle
biopsies were analyzed,
showing reductions in
mitochondrial content and
suppression of mitochondrial
regulatory proteins Sirt3,
PGC-1α, NRF-1,
and cytochrome C in ICF
group compared to NF group.
Filler et al., 2014 [103]
Review; 25 papers of
which 20 included patients
with CFS/ME, which are
summarized here.
Compare associations
between fatigue and
outcomes of
mitochondrial function.
-
Most evidence for lower
serum levels of CoQ10 in
patients with CFS
(4/4 studies). Other findings
included reduced carnitine
levels (4/5 studies);
decreased antioxidant levels
(2/2 studies); changes in
mitochondrial structure
(3/4 studies); and impaired
energy production
(2/4 studies).
Lacourt et al., 2018 [43]
Review; 46 papers of
which 12 included CRF, 20
CFS and 14 animal models.
Compare associations
between low-grade
inflammation and imbalance
in energy availability
and expenditure.
-
Most evidence for
an association between
fatigue and mitochondrial
functioning comes from CFS,
indicating lower levels of
antioxidants and possible
reductions in mitochondrial
ATP production.
CFS = chronic fatigue syndrome; ME = myalgic encephalomyelitis; CRF = cancer related fatigue; ICF = idiopathic
chronic fatigue; NF = non-fatigued; CDC = Centers for Disease Control and Prevention; BMI = body mass index;
Sirt3 = sirtuin-3; PGC-1α = Peroxisome proliferator-activated receptor-gamma coactivator-1alpha; NRF-1 = Nuclear
respiratory factor 1; CoQ10 = Coenzyme Q10.
6. Mitochondrial Dysfunction and Fatigue
Although there are several mechanisms underlying sarcopenia, mitochondrial dysfunction in skeletal
myocytes is considered to be a major factor in age-related muscle decline [102,104]. Mitochondrial damage
seems to mark the aging process and vice versa. It is well known that mitochondrial function declines
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with aging [105] and this might contribute to the onset of age-related conditions [41]. Mitochondria
play a pivotal role in bioenergetics, particularly in high energy-demanding tissues like the muscle [106].
Furthermore, mitochondria are a major source of cellular reactive oxygen species (ROS). Under physiologic
conditions, ROS mediate cell signaling and survival [107]. However, when in excess, ROS can damage
intracellular macromolecules such as proteins, lipids and nucleic acids [102]. Mitochondria are the main
source of energy production through the process of oxidative phosphorylation, in which nutrients are
harnessed to generate ATP [103,108]. Energy shortage secondary to mitochondrial dysfunction may
result in decreased stamina and fatigue [103] (Table 2). Furthermore, inflammation has been linked to
mitochondrial dysfunction and oxidative stress [104,109,110]. Pro-inflammatory mediators can, in fact,
alter both mitochondrial energy metabolism and function, which, in turn, promote inflammation via
oxidant generation and release of damage-associated molecular patterns (DAMPS) [109,110]. Interestingly,
fatigue is often observed in many disease conditions characterized by both inflammation and mitochondrial
dysfunction [111]. However, given its complexity, the symptom of fatigue cannot be completely explained
by a single disease or mechanism. Nevertheless, the central role played by mitochondrial function for
many age-related biological pathways may support the identification of the organelles in the generation
of the fatigue symptom. In other words, fatigue may become the multidimensional, clinical manifestation
of mitochondrial dysfunction.
Mitochondrial dysfunction can also lead to increased anaerobic metabolism and the production
of lactic acid. This is also an interesting concern since acidosis in skeletal muscle can be perceived
as muscular fatigue [4]. As a whole, mitochondrial derangements may help better understand
the possible link between aging, muscle decline and fatigue, given their role in energy and ROS
production [14,102,112].
7. Nutritional Interventions
As discussed above, fatigue may be perceived at the muscular level. Thus, nutritional interventions
targeted to counteract muscle decline could theoretically also be beneficial in the context of fatigue.
Older adults need more proteins to preserve muscle mass compared to younger people [113]. In fact,
both the European Society for Clinical Nutrition and Metabolism (ESPEN) [114] and PROT-AGE
study group [113] agreed that the current recommended dietary allowance (RDA) for proteins
(0.8 g/Kg Body Weight/day) is not sufficient for older persons. Therefore, it has been suggested to
increase daily protein assumption at 1–1.2 g/kg body weight/day and up to 1.5 g/Kg/day in the presence
of acute or chronic diseases to maintain muscle [113,114]. Furthermore, the per-meal anabolic threshold
of protein intake seems to be higher in older individuals (i.e., 25 to 30 g protein/meal, containing about
2.5 to 2.8 g leucine) than young adults [113]. In addition to protein amount, protein source is also
important. Plant-based proteins are considered to have a less anabolic effects (partly due to their low
content in essential amino acids and leucine) than animal proteins [113,115]. However, it has been
suggested that an adequate protein intake can also be achieved by combining plant-based and animal
protein sources [115]. Additionally, fast digested proteins seem to better stimulate muscle protein
accretion, even if results should be confirmed in larger trials [113]. Some proteins are metabolized to
short chain fatty acids (i.e., propionate, butyrate and acetate) which are used by muscle cells to produce
energy [116–119]. Short chain fatty acids also promote muscle anabolism and display anti-inflammatory
proprieties [120–123]. Therefore, it would be interesting to see if protein supplementation may also
exert its beneficial effect in alleviating fatigue symptoms.
However, most evidence for an association between dietary components and fatigue comes from
chronic fatigue syndrome (CFS). In particular, some nutritional deficiencies (vitamin C, B vitamins,
sodium, magnesium, zinc, folic acid, L-carnitine, L-tryptophan, essential fatty acids, coenzyme Q10)
have been reported in CFS subjects [74,124]. Nevertheless, most of the nutritional deficiencies which can
contribute to the CFS are frequently observed in older people. Indeed, nutritional treatments targeted to
CFS may also have beneficial effects in older adults complaining fatigue. It is important to bear in mind
that fatigue, even though is often largely unexplained, may also be the manifestation of an underlying
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distressing condition. Indeed, each intervention requires a multidimensional approach. Nutritional
interventions in older people should be individually adjusted taking into account some components
(i.e., nutritional status, physical activity level, disease status) [125]. Some dietary components seem to
be promising against the symptom of fatigue. Interestingly, acetyl L-carnitine administration has been
reported to reduce both mental and physical fatigue in older people [126] and vitamin D deficiency
has been associated with both mental and physical fatigue [101]. Given that fatigue often has been
suggested to be due to inflammation and oxidative stress, antioxidant supplementation has been
proposed as a strategy to reduce fatigue [43]. Nicotinamide adenine dinucleotide and coenzyme Q10
has been reported to reduce fatigue in CFS patients [127,128]. Additionally, in animal models, it has
been documented that antioxidants can lead to a reduction of fatigue [43]. However, the evidence in
humans is still sparse [129].
8. Conclusions and Future Perspectives
Although fatigue is symptom frequently complained of by older adults, its underlying mechanisms
are still incompletely understood. This gap in the knowledge contributes to the poor medical attention
to fatigue. Modifications in food intake and changes in body composition, alone or in combination
with sleep disorders, seem to influence the perception of fatigue, probably through the mechanisms
of inflammation and mitochondrial dysfunction. The history of fatigue may potentially follow what
already occurred for the management of pain and depression, conditions similar/related to fatigue
which were once neglected but are today major conditions in clinics and research. As occurred for
pain and depression, fatigue will obtain the attention it deserves when dedicated research will be
developed on this issue, its underlying biological mechanisms will be clarified, possible targets for
pharmacological and non-pharmacological interventions will be detected, and awareness will be
increased in the medical community.
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